USTAR MultNAT MTB/RIF Assay officially approved by the China National Medical Products Administration (NMPA)!
A “Global Solution” for innovating the diagnosis of drug-resistant tuberculosis.
Ustar Biotech and University Indonesia officially signed a Memorandum of Understanding (MoU) in Jakarta
University Indonesia, was founded in 1849. It is the oldest higher education institution in Indonesia and a world-leading research university
Ustar Biotechnology’s Monkeypox Virus Assays Receive WHO Emergency Use Listing (EUL).
The first cerctificate in China, which passed WHO Emergency Use Listing (EUL) approval for the Ustars’ Molecular POC Monkeypox Virus (MPXV ) Assay
EasyNAT Nucleic Acid Amplification and Detection Analyzer
Solution for Screening with Rapid and Accurate Results
MultNAT Molecular Diagnostic Testing System
For Multiplex, Drug Resistence and Quantatitive Testing
PortNAT Molecular Diagnostic Testing System
Designed for primary healthcare systems
